D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$773M |
| 2 |
Visa
V
|
+$674M |
| 3 |
HES
Hess
HES
|
+$541M |
| 4 |
Mastercard
MA
|
+$448M |
| 5 |
Oracle
ORCL
|
+$419M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
Advanced Micro Devices
AMD
|
+$979M |
| 3 |
Citigroup
C
|
+$477M |
| 4 |
Exxon Mobil
XOM
|
+$434M |
| 5 |
Booking.com
BKNG
|
+$355M |
Sector Composition
| 1 | Technology | 27.95% |
| 2 | Consumer Discretionary | 14.18% |
| 3 | Financials | 9.99% |
| 4 | Healthcare | 9.55% |
| 5 | Communication Services | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Schwab Fundamental US Small Company Index ETF
FNDA
$9.01B
| $4.61M | ﹤0.01% |
+161,516
| New | +$4.61M |
|
|
PETQ
1202
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $4.59M | ﹤0.01% |
251,200
-21,408
| -8% | -$391K |
|
1203
Ligand Pharmaceuticals
LGND
$3.23B
| $4.58M | ﹤0.01% |
62,592
-25,317
| -29% | -$1.85M |
|
1204
Telos
TLS
$490M
| $4.57M | ﹤0.01% |
1,099,688
-67,951
| -6% | -$283K |
|
1205
Oscar Health
OSCR
$5B
| $4.56M | ﹤0.01% |
306,991
-276,582
| -47% | -$4.11M |
|
|
SRCL
1206
DELISTED
Stericycle Inc
SRCL
| $4.56M | ﹤0.01% |
86,417
+20,673
| +31% | +$1.09M |
|
1207
Antero Midstream
AM
$8.91B
| $4.55M | ﹤0.01% |
323,461
+32,118
| +11% | +$452K |
|
1208
Phillips 66
PSX
$52.9B
| $4.54M | ﹤0.01% |
27,818
-46,132
| -62% | -$7.54M |
|
1209
American Eagle Outfitters
AEO
$3.18B
| $4.54M | ﹤0.01% |
176,136
-2,046,356
| -92% | -$52.8M |
|
1210
SPS Commerce
SPSC
$4B
| $4.53M | ﹤0.01% |
24,494
+18,331
| +297% | +$3.39M |
|
|
ETWO
1211
DELISTED
E2open Parent Holdings
ETWO
| $4.51M | ﹤0.01% |
1,016,390
+95,358
| +10% | +$423K |
|
1212
E.W. Scripps
SSP
$257M
| $4.47M | ﹤0.01% |
1,137,597
+608,996
| +115% | +$2.39M |
|
1213
Tri Pointe Homes
TPH
$3.09B
| $4.45M | ﹤0.01% |
115,219
+7,579
| +7% | +$293K |
|
1214
RE/MAX Holdings
RMAX
$195M
| $4.45M | ﹤0.01% |
507,606
+223,954
| +79% | +$1.96M |
|
1215
Supernus Pharmaceuticals
SUPN
$2.55B
| $4.45M | ﹤0.01% |
130,366
+1,213
| +0.9% | +$41.4K |
|
1216
Universal Insurance Holdings
UVE
$719M
| $4.44M | ﹤0.01% |
218,659
-22,691
| -9% | -$461K |
|
1217
Chevron
CVX
$317B
| $4.44M | ﹤0.01% |
28,129
-320,776
| -92% | -$50.6M |
|
1218
uniQure
QURE
$904M
| $4.42M | ﹤0.01% |
850,100
+289,769
| +52% | +$1.51M |
|
1219
Schwab US REIT ETF
SCHH
$8.43B
| $4.42M | ﹤0.01% |
+217,616
| New | +$4.42M |
|
1220
BRF SA
BRFS
$6.22B
| $4.41M | ﹤0.01% |
1,351,906
+672,254
| +99% | +$2.19M |
|
1221
Maxeon Solar Technologies
MAXN
$65M
| $4.4M | ﹤0.01% |
13,205
+2,185
| +20% | +$728K |
|
|
LCW
1222
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
| $4.39M | ﹤0.01% |
400,200
| – | – |
|
1223
Haleon
HLN
$43.9B
| $4.39M | ﹤0.01% |
+517,013
| New | +$4.39M |
|
1224
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $4.38M | ﹤0.01% |
221,853
-82,752
| -27% | -$1.63M |
|
1225
Paymentus
PAY
$4.1B
| $4.36M | ﹤0.01% |
191,807
+32,374
| +20% | +$737K |
|